Test Price
2,800 AED✅ Home Collection Available
FKTN Gene Walker-Warburg Syndrome NGS Genetic Test in Dubai, UAE
Executive Summary & Core Metrics
This advanced Next-Generation Sequencing (NGS) test provides 99.9% diagnostic sensitivity for pathogenic variants in the FKTN gene, confirming Walker-Warburg syndrome with exceptional precision. The test is processed at a DHA-licensed facility (License No. 1143) under ISO 9001:2015 accreditation. Premium logistics include VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM. Post-test telephonic clinical guidance is provided by a DHA-registered Consultant Medical Geneticist for comprehensive result interpretation. Direct insurance billing verification is available via WhatsApp at +971 54 548 8731, with most major UAE insurer networks accepted.
Test Overview & Methodology
This comprehensive NGS assay analyses the entire coding region and splice sites of the FKTN gene, including copy number variation (CNV) detection. Walker-Warburg syndrome (WWS) is a severe autosomal recessive congenital muscular dystrophy characterised by type II lissencephaly, cerebellar malformations, and anterior chamber eye abnormalities. Genetic confirmation via NGS is essential for accurate prognosis, family planning, and early intervention. The test is recommended for infants and children with suspected WWS, as well as at-risk couples with a family history seeking carrier screening.
| Feature | DNA Labs UAE NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Full gene NGS with intronic coverage and CNV analysis | Targeted exon-only Sanger sequencing |
| Diagnostic Yield | 99.9% sensitivity for known pathogenic variants | ~85% sensitivity – may miss deep intronic or structural variants |
| Turnaround Time | 3 – 4 weeks | 4 – 6 weeks |
| Price | 2,800 AED | 2,500 – 3,000 AED (varies) |
| Regulatory Oversight | DHA Facility License No. 1143 • ISO 9001:2015 | May lack direct DHA registration |
Physician Insight & Safety Protocols
"As a Consultant Medical Geneticist registered with the DHA, I recommend this advanced NGS test for families in the UAE with suspected Walker-Warburg syndrome. The comprehensive coverage and high sensitivity provide crucial molecular confirmation. However, definitive diagnosis must always be correlated with clinical phenotype, neuroimaging, and muscle histology. Genetic results should never be interpreted as standalone diagnostic evidence."
— Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
Medication Advisory Do Not Self-Adjust Treatment
Do not discontinue, initiate, or modify any prescribed medication or treatment plan based solely on the results of this genetic test. Always consult your child's treating paediatric neurologist or a qualified DHA-licensed specialist before making any therapeutic changes.
Safety Exclusion & Emergency Red Flags
Exclusion Criteria
- Individuals under 18 years without legal guardian informed consent.
- Recent blood transfusion less than 2 weeks prior to sample collection (may affect DNA quality).
- Inability to comprehend genetic implications – a mandatory pre-test counselling session is required.
Emergency Red Flags
- Sudden uncontrolled seizures or prolonged apnoea in an infant.
- Acute visual loss or new-onset severe hypotonia.
- Respiratory distress or cyanosis.
This genetic test is not designed for acute emergency diagnosis. Seek immediate emergency medical attention if any of the above occur.
Patient FAQ & Clinical Guidance
1. What does the FKTN gene Walker-Warburg syndrome NGS test detect and who should consider it?
This NGS test detects pathogenic variants throughout the entire FKTN gene with a diagnostic sensitivity of 99.9%. It is indicated for infants and children presenting with congenital muscular dystrophy, type II lissencephaly, and ocular abnormalities consistent with Walker-Warburg syndrome. It is also recommended for couples with a positive family history who are seeking carrier screening and reproductive counselling. The test is performed on a single peripheral blood sample collected via our VIP home phlebotomy service or at our DHA-licensed facility in Dubai Healthcare City.
2. How long does it take to receive the FKTN genetic test results?
The standard turnaround time for the FKTN NGS test is 3 to 4 weeks from sample collection to final clinical report. Results are delivered via a secure electronic portal, and a telephonic consultation with a DHA-licensed Consultant Medical Geneticist is included to explain the findings and their implications. Our ISO 9001:2015 accredited laboratory ensures rigorous quality control throughout the sequencing and interpretation process.
3. Is the FKTN genetic test covered by health insurance in the UAE?
DNA Labs UAE facilitates direct insurance billing verification for most major UAE health insurance networks. To confirm your coverage, send your policy details via WhatsApp to +971 54 548 8731. Our team will process a pre-approval request and provide direct billing confirmation before sample collection. Coverage varies by insurer and plan; please verify prior to booking.
4. What sample type is required for this genetic test and how is it collected?
The test requires a standard peripheral whole blood sample (3–5 mL) collected in an EDTA tube. Our VIP Mobile Phlebotomy service is available daily from 8 AM to 11 PM, including home collection via temperature-controlled cold-chain logistics. Alternatively, samples can be collected at our DHA-licensed facility in Dubai Healthcare City. No special dietary preparation is required.
UAE Regulatory & Data Privacy Adherence
Strict Compliance with UAE Data Protection Frameworks
DNA Labs UAE adheres fully to the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, stored on secure UAE-based servers, and accessed only by authorised clinical personnel. Patient consent is obtained prior to testing, and no genetic information is shared with third parties without explicit written authorisation. Clinical testing safety and informed consent protocols conform to Federal Decree-Law No. 4 of 2016 on Medical Liability. Our DHA Facility License No. 1143 is active and verified by the Dubai Health Authority.
Clinical & Logistical Metadata
| Test Name | FKTN Gene Next-Generation Sequencing for Walker-Warburg Syndrome |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 – 4 weeks |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL EDTA) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM |
| Methodology Used | Next-Generation Sequencing (NGS) with CNV analysis; full gene coverage of coding regions, splice sites, and selected intronic regions |
| ICD-10-CM Code | Q04.3 – Other reduction deformities of brain (Walker-Warburg syndrome) |
| LOINC Code | 94219-4 – FKTN gene full sequencing analysis |
| DHA Facility License & Laboratory Address | License No. 1143 • Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE • DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians